Senate - 11/18/2020 Received in the Senate and Read twice and referred to the Committee on the Judiciary. (All Actions)
Tracker:
This bill has the status Passed House
Here are the steps for Status of Legislation:
Introduced
Array
(
[actionDate] => 2020-11-16
[displayText] => Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-583, Part I.
[externalActionCode] => 5000
[description] => Introduced
[chamberOfAction] => House
)
Passed House
Array
(
[actionDate] => 2020-11-17
[displayText] => Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5816-5817)
[externalActionCode] => 8000
[description] => Passed House
[chamberOfAction] => House
)
Block, Report, And Suspend Suspicious Shipments Act of 2020
Official Titles
Official Titles - House of Representatives
Official Title as Introduced
To amend the Controlled Substances Act to clarify the process for registrants to exercise due diligence upon discovering a suspicious order, and for other purposes.
Actions Overview (4)
Date
Actions Overview
11/17/2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5816-5817)
11/16/2020
Committee on the Judiciary discharged.
11/16/2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-583, Part I.
07/23/2019
Introduced in House
11/17/2020 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5816-5817)
11/16/2020 Committee on the Judiciary discharged.
11/16/2020 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-583, Part I.
07/23/2019 Introduced in House
All Actions (16)
Date
Chamber
All Actions
11/18/2020
Senate
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
11/17/2020-1:30pm
House
Motion to reconsider laid on the table Agreed to without objection.
11/17/2020-1:30pm
House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5816-5817)
11/17/2020-1:24pm
House
DEBATE - The House proceeded with forty minutes of debate on H.R. 3878.
11/17/2020-1:24pm
House
Considered under suspension of the rules. (consideration: CR H5816-5818)
11/17/2020-1:23pm
House
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
11/16/2020
House
Placed on the Union Calendar, Calendar No. 481.
11/16/2020
House
Committee on the Judiciary discharged.
11/16/2020
House
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-583, Part I.
09/09/2020
House
Ordered to be Reported (Amended) by Voice Vote. Action By: Committee on Energy and Commerce
09/09/2020
House
Committee Consideration and Mark-up Session Held. Action By: Committee on Energy and Commerce
08/15/2019
House
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Action By: Committee on the Judiciary
07/24/2019
House
Referred to the Subcommittee on Health. Action By: Committee on Energy and Commerce
07/23/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/23/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/23/2019
House
Introduced in House
11/18/2020 Received in the Senate and Read twice and referred to the Committee on the Judiciary.
11/17/2020 Motion to reconsider laid on the table Agreed to without objection.
11/17/2020 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5816-5817)
11/17/2020 DEBATE - The House proceeded with forty minutes of debate on H.R. 3878.
11/17/2020 Considered under suspension of the rules. (consideration: CR H5816-5818)
11/17/2020 Mr. Pallone moved to suspend the rules and pass the bill, as amended.
11/16/2020 Placed on the Union Calendar, Calendar No. 481.
11/16/2020 Committee on the Judiciary discharged.
11/16/2020 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-583, Part I.
09/09/2020 Ordered to be Reported (Amended) by Voice Vote.
09/09/2020 Committee Consideration and Mark-up Session Held.
08/15/2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
07/24/2019 Referred to the Subcommittee on Health.
07/23/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/23/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.
Shown Here: Reported to House, Part I (11/16/2020)
Block, Report, And Suspend Suspicious Shipments Act of 2020
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.
In addition to reporting the suspicious order to the Drug Enforcement Administration, a manufacturer or distributor must also exercise due diligence and decline to fill the order.
Shown Here: Reported to House, Part I (11/16/2020)
Block, Report, And Suspend Suspicious Shipments Act of 2020
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.
In addition to reporting the suspicious order to the Drug Enforcement Administration, a manufacturer or distributor must also exercise due diligence and decline to fill the order.
Shown Here: Introduced in House (07/23/2019)
Block, Report, And Suspend Suspicious Shipments Act of 2019
This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.
In addition to reporting the suspicious order to the Drug Enforcement Administration, a manufacturer or distributor must also exercise due diligence and decline to fill the order.